Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors

BACKGROUND: HER2 is one of the most extensively studied oncogenes in solid tumors. However, the association between tumor microenvironment (TME) and HER2 mutation remains elusive, and there are no specific therapies for HER2-mutated tumors. Immune checkpoint inhibitors (ICIs) have been approved for...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Deqiang, Chen, Xiaofeng, Du, Yian, Li, Xiaoqin, Ying, Leqian, Lu, Yi, Shen, Bo, Gao, Xuan, Yi, Xin, Xia, Xuefeng, Sui, Xinbing, Shu, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905508/
https://www.ncbi.nlm.nih.gov/pubmed/35281032
http://dx.doi.org/10.3389/fimmu.2022.799988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905508/
https://www.ncbi.nlm.nih.gov/pubmed/35281032
http://dx.doi.org/10.3389/fimmu.2022.799988

Ejemplares similares